ALIROCUMAB | B125559 | REGENERON PHARMACEUTICALS
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 7-Year Orphan | Apr. 1, 2028 | Active | Purple Book |
| 12-Year BPCIA | Jul. 24, 2027 | Active | Computed |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12389888(manufacturing) · relevance 75/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Top 50 of 238 AI-discovered patents by relevance.
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2014-11-11 | Terminated 2017-01-05 | — | |
| D. Del. | 2014-10-28 | Terminated 2017-01-05 | — | |
| D. Del. | 2014-10-17 | Terminated 2019-10-03 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.